Rare Account Director - East

SpringWorks Therapeutics

2 months ago

4.2 on Glassdoor

United States

Hybrid

Full Time

Senior

1 applicant

View Job Listing

Apply to 100+ jobs

About this role

SpringWorks Therapeutics is a commercial-stage biopharmaceutical company focused on improving the lives of patients with rare tumors. The Rare Tumors Key Account Director is a field-based Market Access leader responsible for executing the rare tumor market access strategy across the portfolio and strengthening partnerships with community oncology GPOs, super groups, and IDNs. The role aims to heighten awareness of rare tumors and improve patient access to approved therapies.

Skills

Qualifications

Bachelor's DegreeAdvanced Degree (Preferred)Valid Driver's License

About SpringWorks Therapeutics

springworkstx.com

SpringWorks Therapeutics is a commercial-stage biopharmaceutical company that applies a precision‑medicine approach to discover, develop, and deliver targeted therapies for severe rare diseases and cancer. Focused on targeted oncology, the company pursues potential breakthrough medicines with scientific rigor, urgency, and a patient‑centric mindset. SpringWorks combines research and development expertise with commercial capabilities to advance and bring life‑changing treatments to patients.

Recent company news

Merck Group

Merck Completes Acquisition of SpringWorks Therapeutics to Accelerate Sustainable Growth of its Healthcare Business

Jul 1, 2025

Fierce Biotech

Merck KGaA drops pipeline assets from SpringWorks buyout, Hengrui licensing deal

1 week ago

World Pharmaceutical Frontiers

Merck completes $3.4bn acquisition of SpringWorks Therapeutics

Jul 2, 2025

Law360

Biopharma Co. Can't Beat Former Exec's Age, Race Bias Suit

3 days ago

Yahoo Finance

SpringWorks Therapeutics Announces Publication of Long-Term Efficacy and Safety Data from the Phase 3 DeFi Trial of OGSIVEO® (nirogacestat) in Adults with Desmoid Tumors in the Journal of Clinical Oncology

Oct 20, 2025